Pharmakon Pharmaceuticals recalls Lidocaine HCI (PF) Inj, USP 2%, injectable packed in syringes, Total dosage 100 mg/ 5mL, Rx only, PHARMAKON Pharmaceuti…
- Recall date
- August 19, 2015
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Recall number
- D-0604-2016
- FDA classification
- Class II
- Brand / firm
- Pharmakon Pharmaceuticals
- Sold / distributed
- Nationwide
Why it was recalled
Stability data does not support expiry.
Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What was recalled
Lidocaine HCI (PF) Inj, USP 2%, injectable packed in syringes, Total dosage 100 mg/ 5mL, Rx only, PHARMAKON Pharmaceuticals, Inc.
Get recall alerts
Free email alert whenever Pharmakon Pharmaceuticals has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: Pharmakon Pharmaceuticals